Sprycel 140 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FTA08
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,948
Award facts
- Contract value 100% obligated
- $5,947.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $5,947.75 to DMS Pharmaceutical Group Inc. for the supply of Sprycel 140 mg tablets (30-count units). This firm fixed-price delivery order was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025, and will be performed in Park Ridge, Illinois. The award carries no set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis despite its status as a woman-owned small business.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.9 billion vehicle valued through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products for military health facilities worldwide. DMS Pharmaceutical Group, a pharmaceutical wholesaler headquartered in Park Ridge, Illinois, and registered in SAM.gov since 2001, serves as a critical supplier within the federal pharmaceutical supply chain, distributing branded and generic prescription drugs, biologics, and medical consumables to Department of Defense healthcare sites. Sprycel (dasatinib) is an oncology medication used in the treatment of certain blood cancers, reflecting the company's role in supplying specialized pharmaceutical products to support military medical operations.
Quick answers
Who was awarded contract SPE2DB25FTA08?
SPE2DB25FTA08 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 25, 2025.
How much is contract SPE2DB25FTA08 worth?
The government has obligated $5,948 on SPE2DB25FTA08.
Is contract SPE2DB25FTA08 an order under another contract?
Yes. SPE2DB25FTA08 is a delivery order under SPE2DB22D9367, an indefinite delivery contract.
Was contract SPE2DB25FTA08 competed?
The extent of competition for SPE2DB25FTA08 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award